Ionis Pharmaceuticals IONS Income Tax Reconciliation Change In Enacted Tax Rate
Income Tax Reconciliation Change In Enacted Tax Rate at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate.
The official record: Ionis Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's income tax reconciliation change in enacted tax rate.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's income tax reconciliation change in enacted tax rate?
- Ionis Pharmaceuticals (IONS) reported income tax reconciliation change in enacted tax rate of $2.7M in Q4 2024.
- How has Ionis Pharmaceuticals's income tax reconciliation change in enacted tax rate changed year-over-year?
- Ionis Pharmaceuticals's income tax reconciliation change in enacted tax rate increased by 957.2% year-over-year, from $255.75K to $2.7M.
- What does income tax reconciliation change in enacted tax rate mean?
- The financial impact of changes in tax laws on the company's deferred tax balances.
- How do you interpret income tax reconciliation change in enacted tax rate?
- A positive value indicates a benefit from tax rate changes, while a negative value indicates a charge.
- How does income tax reconciliation change in enacted tax rate compare across companies?
- Varies significantly based on the timing of tax legislation changes in operating jurisdictions.